MBX Biosciences, Inc. (MBX)

MBX Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	29.9	49.35	30.52	24.21
Short-Term Investments	210.88	212.8	50.15	18.25
Cash & Short-Term Investments	240.79	262.15	80.68	42.46
Cash Growth	242.43%	224.94%	90.00%	-
Other Receivables	1.39	0.68	0.21	0.14
Receivables	1.39	0.68	0.21	0.14
Prepaid Expenses	1.48	3.65	2.45	1.52
Other Current Assets	0.63	0.8	0.13	0.08
Total Current Assets	244.28	267.29	83.47	44.21
Property, Plant & Equipment	1.6	1.2	0.67	0.84
Other Long-Term Assets	0.05	0.05	0.05	0.04
Total Assets	245.93	268.54	84.18	45.1
Accounts Payable	4.25	5.34	1.39	0.98
Accrued Expenses	6.11	5.55	2.38	2.32
Current Portion of Leases	0.13	0.17	0.15	0.14
Total Current Liabilities	10.48	11.05	3.93	3.43
Long-Term Leases	-	-	0.17	0.32
Other Long-Term Liabilities	0.02	0.04	0.19	0.07
Total Liabilities	10.5	11.09	4.29	3.82
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	396.75	394.89	3.05	0.41
Retained Earnings	-161.39	-137.51	-75.58	-43.02
Comprehensive Income & Other	0.05	0.06	0.06	0
Total Common Equity	235.42	257.44	-72.47	-42.61
Shareholders' Equity	235.42	257.44	79.89	41.27
Total Liabilities & Equity	245.93	268.54	84.18	45.1
Total Debt	0.13	0.17	0.32	0.46
Net Cash (Debt)	240.66	261.98	80.35	42
Net Cash Growth	243.65%	226.04%	91.31%	-
Net Cash Per Share	12.87	24.62	78.87	62.97
Filing Date Shares Outstanding	33.42	33.42	1.26	0.67
Total Common Shares Outstanding	33.42	33.42	1.26	0.67
Working Capital	233.8	256.24	79.54	40.78
Book Value Per Share	7.04	7.70	-57.65	-63.87
Tangible Book Value	235.42	257.44	-72.47	-42.61
Tangible Book Value Per Share	7.04	7.70	-57.65	-63.87
Machinery	1.11	1.11	0.24	0.23
Construction In Progress	0.51	-	0	-
Leasehold Improvements	0.39	0.39	0.37	0.35

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q